The disclosure provides, inter alia, alpha-5 beta-1 inhibitors, pharmaceutical compositions comprising alpha-5 beta-1 inhibitors, methods for treating diseases using alpha-5 beta-1 inhibitors, and processes for making alpha-5 beta-1 inhibitors.
On the Importance of an Acid Additive in the Synthesis of Pyrido[1,2‐
<i>a</i>
]benzimidazoles by Direct Copper‐Catalyzed Amination
作者:Kye‐Simeon Masters、Tom R. M. Rauws、Ashok K. Yadav、Wouter A. Herrebout、Benjamin Van der Veken、Bert U. W. Maes
DOI:10.1002/chem.201100574
日期:2011.5.27
8‐substituted pyrido[1,2‐a]benzimidazoles (4) has been developed by a direct intramolecular CH amination of N‐phenylpyridin‐2‐amines (3). Efficient CH amination of 3 could only be achieved in the presence of catalytic copper and an acid additive. The type of acid (pKa) proved to be crucial for the catalysis. CCl aminations in N‐(2‐chloroaryl)pyridin‐2‐amines allow access to 9‐substituted pyrido[1,2‐a]benzimidazoles